NASDAQ: ORIQOrigin Investment Corp I Stock
$10.24+0.00 (+0%)
Updated May 1, 2026
ORIQ Price
$10.24
Fair Value Price
$0.34
Market Cap
$88.32M
52 Week Low
$9.98
52 Week High
$10.24
P/E
78.77x
P/B
81.4x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$683.10k
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.16
Operating Cash Flow
-$695k
Beta
-0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ORIQ Overview
A blank check company (SPAC), incorporated in 2024 in the Cayman Islands and based in Singapore. It seeks a business combination with one or more businesses in sectors such as financial services, technology, biotechnology and pharmaceuticals, advanced materials, and clean energy, with a focus on targets in Asia
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ORIQ's potential to beat the market
- ORIQ doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
ORIQ
RankedUnranked of 36
RankedUnranked of 36
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.54 | C | |
| $11.13 | C | |
| $10.23 | C |
Be the first to know about important ORIQ news, forecast changes, insider trades & much more!
ORIQ News
Overview
Due Diligence Score
–
Industry Average (10)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ORIQ scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ORIQ ($10.24) is overvalued by 2,942.79% relative to our estimate of its Fair Value price of $0.34 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ORIQ ($10.24) is not significantly undervalued (2,942.79%) relative to our estimate of its Fair Value price of $0.34 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ORIQ is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
There are 30 more ORIQ due diligence checks available for Premium users.
Valuation
ORIQ fair value
Fair Value of ORIQ stock based on Discounted Cash Flow (DCF)
Price
$10.24
Fair Value
$0.34
Overvalued by
2,942.79%
ORIQ ($10.24) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ORIQ ($10.24) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ORIQ price to earnings (PE)
For valuing profitable companies with steady earnings
Company
78.77x
Industry
-55.28x
Market
18.83x
ORIQ is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ORIQ is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
ORIQ price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
81.4x
Industry
30.76x
ORIQ is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ORIQ's financial health
Profit margin
Revenue
$0.0
Net Income
$419.5k
Profit Margin
0%
ORIQ's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$72.3M
Liabilities
$174.9k
Debt to equity
0.16
ORIQ's short-term assets ($1.26M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ORIQ's short-term assets ($1.26M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ORIQ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$277.2k
Investing
$0.0
Financing
$0.0
ORIQ's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ORIQ vs Shell Company Stocks
Origin Investment I Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.